-
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Recommendation of "Buy" by Analysts
Source: Buzz FX / 02 Jan 2025 05:51:13 America/New_York
Trevi Therapeutics, Inc. (NASDAQ:TRVI) Given Consensus Recommendation of "Buy" by Analysts Written by MarketBeat January 2, 2025 Share Link copied to clipboard. Trevi Therapeutics, Inc. ( NASDAQ:TRVI - Get Free Report ) has been assigned an
Read more...